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INTRODUCTION
Cytotoxic CD8 + T cells help clear intracellular bacterial and viral infections and protect against future infections by forming a long-lived, rapidly responding population of memory T cells. During an acute viral infection, the pathogen-specific CD8 + T cells develop into a heterogeneous population of cytotoxic effector and memory T cells, comprised of subsets discernable by their phenotypes, functions, anatomical locations, and longterm fates (Kaech and Cui, 2012 (Kaech and Cui, 2012) . However, the TE cells have the least memory cell potential and display the greatest rates of contraction after infection. TE cells are considered terminally differentiated because they proliferate poorly in response to homeostatic cytokines (e.g., IL-15) or antigen and maintain their phenotypic and functional properties upon restimulation (i.e., they do not adopt properties of other effector subsets) (Joshi et al., 2007) . In contrast, subsets of memory precursor (MP) effector cells (distinguished by higher expression of IL-7Ra ]) are intrinsically more fit to persist and self-renew (Joshi et al., 2007; Best et al., 2013; Sarkar et al., 2008) . The MP cells are also multipotent, developing into diverse types of memory CD8 + T cells (e.g., central, effector, and resident memory T cells) that form recalled effector cells upon secondary infection (Sarkar et al., 2008; Mackay et al., 2013; Joshi et al., 2007) . Given that these CD8 + T cell fate decisions determine the quantity and quality of immunological memory that forms after vaccination and infection, it is critical to understand how and when they are specified. Temporal regulation of effector CD8 + T cell differentiation and the factors involved have begun to be delineated. Even as early as the first cell division, asymmetric partitioning of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and 2 and the transcription factors (TFs) c-Myc and T-bet biases the daughters cells toward effector or memory cell fates (Chang et al., 2011; Verbist et al., 2016; Pollizzi et al., 2016) . Other studies have shown that commitment to a TE cell fate can be visualized in early effector CD8 + T cells $3.5 to 4.5 days postinfection (p.i.) by increased expression of KLRG1 or the interleukin 2 receptor a (IL-2Ra) chain or reduced expression of the transcription factor ID3 (see references within Kaech and Cui, 2012; Best et al., 2013; Kalia et al., 2010 hi cells that differ in their long-term fates and the types of memory cells they form (Kaech and Cui, 2012) . CD62L hi central memory (Tcm) and CD103 hi tissue-resident memory (Trm) cells progressively form several weeks after infection, demonstrating that effector and memory CD8 + T cell specification is dynamic (Mackay et al., 2013; Kaech and Cui, 2012) . Further, recent work has shown that these memory cells have distinct roles in immune surveillance and homeostasis, distinguished by expression of the chemokine receptor CX3CR1 (Gerlach et al., 2016) . TE versus MP cell differentiation is influenced by cytokines such as type 1 interferons, IL-12, and IL-2, which are transduced through transcription factors STAT4, STAT5, and the AKT and mTOR pathways to induce effector gene expression and repress quiescence and pro-memory genes (see references within Kaech and Cui, 2012) . Increasing levels of inflammation induce graded expression of TFs, including T-bet, ZEB2, and Blimp-1, that cooperatively promote TE-signature gene expression and terminal differentiation (Kaech and Cui, 2012; Dominguez et al., 2015; Shin et al., 2013; Omilusik et al., 2015) . Simultaneously, the AKT-mediated inactivation of the TF FOXO1 represses expression of MP-signature genes, including Il7r, Sell, Tcf7, Lef1, Bach2, and other memory promoting genes (see references within Kaech and Cui, 2012; Kim et al., 2013) . While the above studies offer insight into the molecular control of differentiation of diverse effector T cell subsets during infection, they do not explain how the changes in gene expression are stably inherited in daughter cells to generate terminally differentiated TE cells fated to die or multipotent MP cells fated to persist and generate memory cells.
Dynamic regulation of epigenetic and chromatin states will influence how T cells acquire or lose plasticity and/or how particular T cell fates are determined. To better elucidate the epigenetic mechanisms by which TE cells become committed to a terminal fate and MP cells remain multipotent in the context of changing environments during acute lymphocytic choriomeningitis virus (LCMV) infection, we profiled active chromatin associated histone 3 lysine 27 acetyl (H3K27ac) and repressed chromatin associated histone 3 lysine 27 trimethyl (H3K27me3) 
RESULTS

Epigenetic Repression of Pro-memory Genes in
Terminally Differentiated Effector CD8 + T Cells TE and MP cells differ in their developmental potential (i.e., multipotency) and long-term fates after viral infection, and while they express several genes in common, they also have distinct gene expression signatures (referred to as MP-and TE-signature genes throughout) (Dominguez et al., 2015; Joshi et al., 2007) . To understand how these developmental differences arise, we characterized the epigenetic states of these virus-specific effector CD8 ) were identified across MP and TE ChIP-seq samples (Figures S1A-S1C). These peaks were annotated to the nearest gene transcriptional start site (TSS) ( Figure S1D ). From these annotations, H3K27ac deposition exhibited a positive correlation with gene expression across MP and TE cells ( Figure S1G , left), while H3K27me3 deposition correlated negatively with gene expression ( Figure S1G, right) .
Next, we identified consensus peaks that contained significant differences in the amount of H3K27me3 or H3K27ac deposition (referred to as differentially modified regions [DMRs] ) between MP and TE cells. DMRs were defined as having a fold-change greater than 1.2 with an FDR less than 0.1. Regions failing to meet these criteria were labeled as ''common'' regions between MP and TE cells. As above, these DMRs and common regions were annotated to the nearest TSS (Figures S1E and S1F) to identify related patterns of mRNA expression in MP and TE cells. Volcano plots of the log 2 (fold-change) of H3K27ac deposition showed that, as expected, DMRs with increased H3K27ac in MP cells (cluster 1) or TE cells (cluster 2) were associated with increased mRNA expression in each respective cell population (MP-and TE-signature genes are labeled red and blue, respectively) ( Figure 1A ). In contrast, differential deposition of H3K27me3 showed that MP cells possessed few differentially methylated loci (cluster 3), whereas TE cells had an abundance of highly methylated loci relative to MP cells (cluster 4), many of which were associated with MP-signature genes ( Figure 1B) .
We next plotted a 20 kb window centered on each significant H3K27ac or H3K27me3 DMR and clustered the loci based on the four quadrants defined by the volcano plots ( Figure 1C) . Clusters 1 and 2 show the significant H3K27ac DMRs in MP and TE cells, respectively, and the mRNA expression at many of these loci correlated with the relative greater abundance of H3K27ac within each cell population ( Figure 1C, right) . However, note that the relative ratio of H3K27ac between MP and TE cells at the DMRs in cluster 2 was more similar than those in cluster 1 (Figure 1D) , signifying that MP cells had comparable amounts of histone acetylation at many TE-signature gene loci despite the lowered mRNA expression (possibly indicative of transcriptional poising). Clusters 3 and 4 show the significant H3K27me3 DMRs ( Figure 1C ), wherein one can see that many H3K27me3 DMRs in TE cells correlated with transcriptional repression of MP-signature genes (cluster 4). Similarly, comparing the ratio of H3K27ac to H3K27me3 in TE and MP cells showed that TE cells generally had a bias toward a more repressed state (lower ac/me3 ratio) than MP cells ( Figure 1E ). In summary, these data demonstrated that the most significant, numerous, and substantial changes in H3K27me3 and H3K27ac deposition preferentially occurred at pro-memory, MP-signature genes that were epigenetically and transcriptionally repressed in the TE cells (Figure 1 ). To understand how the epigenetic profiles of individual genes differed between MP and TE cells, we examined several important and well-studied MP-and TE-signature genes. At many MP-signature genes (such as Id3, Tcf7, and Bach2) and pro-survival genes (such as Bcl2) the TE cells contained substantially more H3K27me3 and less H3K27ac deposition than MP cells (Figures 2A and S2) . A similar pattern was also observed at Trm-signature genes (Mackay et al., 2013) including Sik1, Skil, and Cdh1 (Figure S2) , suggesting that epigenetic silencing of these loci in TE cells accounted for their decline in plasticity and longevity. In contrast, there was relatively little H3K27me3 deposition at most pro-effector, TE-signature genes, such as Klrg1, Tbx21 (T-bet), and Prdm1 (Blimp-1), in either TE or MP cells ( Figure 2B ).
Altogether, these data outlined an epigenetic dichotomy between TE and MP cells and illustrated that as effector CD8 + dashed lines denote a ± log 2 transformed fold-change of 1.2. DMRs associated to MP and TE gene expression signatures are labeled as blue and red dots, respectively. All remaining consensus peaks are referred to as ''common'' regions between MP and TE cells (labeled as light gray dots). (C) Deposition of H3K27me3 and H3K27ac in MP and TE cells centered on DMRs ± 10 kb as identified in volcano plots (A and B). Cluster 1 (dark blue) = H3K27ac deposition higher in MP than TE, cluster 2 (light blue) = H3K27ac deposition higher in TE than MP, cluster 3 (green) = H3K27me3 deposition higher in MP than TE, cluster 4 (orange) = H3K27me3 deposition higher in TE than MP. Line plots at top show the summary distributions across each cluster for each H3K27ac and H3K27me3 in MP and TE cells, respectively. Scatterplots on far right show Log 2 (fold-change) of mRNA expression between MP and TE cells for the DMRassociated genes and summaries of entire gene expression distributions across clusters 1-4 or common consensus peaks are shown in boxplots. (D and E) Line plots show the ratios of H3K27ac or H3K27me3 deposition (normalized to common consensus peaks, see Figure S1I ) between MP and TE cells or within MP or TE cells for each cluster. Data shown contain the union of significant consensus peaks identified across two independent biological replicates of ChIP-seq experiments for H3K27ac and H3K27me3 (n = 10-20 mice/group/replicate). See also Figure S1 . T cells terminally differentiated into TE cells, many pro-memory genes were selectively remodeled into a repressive state by the accumulation of H3K27me3. This provided a genomic understanding for how memory cell potential was lost as effector CD8 + T cells terminally differentiated through epigenetic silencing of pro-memory genes. The reciprocal process did not appear to occur in MP cells as they maintained permissive or active chromatin states at both MP-and TE-signature genes. Given that memory cells derived from the MP subset will need to express pro-effector, TE-signature genes quickly upon antigen re-exposure, our data support a view where the TE fate is not epigenetically repressed in MP cells, but rather remains open or poised. These data argue that the MP versus TE cell fate decision process differs from a conventional binary cell fate choice where each cell type represses the fate-determining genes of the ''alternative'' fate. Rather, MP cells maintain multipotency for both memory and effector fates, while TE cells restrict memory fates.
EZH2 Is Required for the Anti-viral CD8
+ T Cell Response To better understand how H3K27me3 deposition was regulated in CD8 + T cells, we generated mice that conditionally deleted Figure 3A) . The latter point demonstrated that EZH2-containing PRC2 was the exclusive writer of de novo H3K27me3 in activated CD8 + T cells.
To examine the role of EZH2 in the anti-viral CD8 + T cell response, we generated mice that conditionally deleted Ezh2 Data shown are representative of two (C-E), three (A), or five (F) independent experiments (n = 4-10 mice/group/experiment for C and F) or cumulative of five independent experiments (n = 21 mice/group) (B). Data are expressed as mean ± SD. *p = 0.02, ****p < 0. Figures 4B and 4C) . Rather, the CD8 + T cells lacking Ezh2 generated effector cells that expressed lower amounts of KLRG1 and IL-7R and increased amounts of CD27 and CD62L, compared to the littermate controls (Figures 4B and 4C ). In addition, the Ezh2-deficient anti-viral CD8 + T cells expressed higher amounts of pro-memory TFs including TCF1 (TCF7), FOXO1, and Eomes and lower amounts of the pro-effector TF T-bet ( Figure 4D) . Similarly, in different genetic models, Ezh2 f/f CD4Cre + mice formed few virus-specific Figure S3D ). Lastly, because EZH2 is known to have non-histone targets in cells (Gunawan et al., 2015) , we examined the phenotypes of virus-specific CD8 + T cells lacking the PRC2 subunit EED by generating Eed f/f CD4Cre + mice that were infected with LCMV-Armstrong. This
showed that the phenotypes of the CD8 + T cells lacking Eed were very similar to those lacking Ezh2 at day 8 p.i. (Figure S4 ). Together, these data suggested that PRC2 (containing both EZH2 and EED) was intrinsically required for the expansion and terminal differentiation of effector CD8 + T cells and that in the absence of PRC2, effector CD8 + T cells acquired more MP-like qualities. Ezh2 deletion in this system was confirmed after completion of tamoxifen treatment by genomic DNA PCR analysis in virusspecific CD8 + T cells, which showed near complete deletion of Ezh2 ( Figure S5 ). This experiment showed that loss of Ezh2 in anti-viral CD8 + T cells after d8 p.i. did not have a major impact on the quantity or quality of memory CD8 + T cells that formed ( Figures 5A-5C ). In agreement, similar numbers and types of memory CD8 + T cells formed in Ezh2 f/f GzmBCre + mice (the non-inducible Cre system described in Figure 3 ) as in the littermate controls at d30 p.i. (Figures 5D-5F ). Thus, EZH2 was critical for naive/effector CD8 + T cell differentiation, but not effector/memory differentiation, in line with the expression pattern of EZH2 in antiviral CD8 + T cells (data not shown). repress pro-memory genes early after activation and that commitment to effector or memory cell fates can be observed prior to d4.5 p.i. (Kalia et al., 2010; Best et al., 2013; Sarkar et al., 2008) , but when are these cell fates precisely determined? We reasoned that delineating when the pro-memory loci are selectively remodeled by PRC2 would help to better temporally define TE cell determination. Therefore, we first examined whether EZH2 was required for the early transcriptional repression of MP-signature genes, such as Tcf7, Foxo1, Bach2, and Id3, in CD8 + T cells during acute infection ( Figure S6 ). This showed that at day 4.5 p.i., the mRNA expression was reduced equivalently in both the Ezh2-deficient and Ezh2-sufficient CD8 + T cells relative to naive CD8 + T cells ( Figure 6A ), indicating that H3K27me3 deposition was not required for the initial transcriptional repression of pro-memory genes during the early effector phase. Next, we monitored when H3K27me3 deposition increased at MP-signature loci (Tcf7 and Bach2) in effector CD8 + T cells and found that it was lower in naive CD8 + T cells and early effector cells at days 1.5 and 4.5 p.i. compared to day 10 TE cells ( Figure 6B ). Figure 6B ). This result suggested that increased H3K27me3 occurred during a late stage of effector T cell differentiation to stabilize repression of promemory genes whose transcription was already shut down in developing TE cells. Moreover, d30 p.i. memory CD8 + T cells displayed low levels of H3K27me3 deposition, comparable to the MP cell population from which most memory cells descended ( Figure 6B ). Altogether, these results delineated a molecular timeline between commitment (early effector phase) and determination (late effector phase) of TE cell fates by revealing that EZH2-epigenetic remodeling was not required for early transcriptional repression of pro-memory genes but was required later to sustain repression. This significant increase in H3K27me3 observed in the late effector phase may represent the quintessential step in TE cell fate determination.
EZH2 Is
FOXO1 Regulates Deposition of H3K27me3 in CD8 + T Cells
What controls PRC2-mediated H3K27me3 deposition at promemory genes in TE cells? We reasoned that key transcription factors involved in MP and TE cell differentiation, such as T-bet, STAT4, and FOXO1, may be involved (Joshi et al., 2007; Kim et al., 2013) . To examine this idea, we performed H3K27me3 ChIP-qPCR at the pro-memory genes Tcf7 had significantly higher amounts (>2-fold) of H3K27me3 at the pro-memory genes Tcf7 and Bach2 ( Figure 7A ). This result suggested that FOXO1 restrained PRC2 activity at such pro-memory loci.
One may predict that if FOXO1 affects H3K27me3 at MPsignature genes, such as Tcf7 and Bach2, its expression may be higher in MP cells and it may preferentially bind to such loci. Figure 7B ). We then examined putative FOXO1 binding sites in the four different clusters of DMRs identified in Figure 1 using previously generated FOXO1 ChIP-seq data (Kim et al., 2013) (GEO: GSE46943) from naive CD8 + T cells. The density of FOXO1 peaks surrounding common consensus peaks (i.e., non-DMRs), H3K27ac DMRs, or H3K27me3 DMRs in MP and TE cells (i.e., clusters 1-4 defined in Figure 1 ) was measured and plotted (Figure 7C ). FOXO1 binding was densely enriched near the H3K27ac common peaks or DMRs in cluster 1, suggesting that FOXO1 generally bound to active genes and open chromatin regions (note, FOXO1 binding was not concentrated proximal to H3K27ac DMRs in TE cells [cluster 2]) ( Figure 7C , top). There were no FOXO1 binding sites in H3K27me3 DMRs in MP cells (cluster 3), but interestingly, FOXO1 binding sites were preferentially and densely enriched near H3K27me3 DMRs found in TE cells (cluster 4) ( Figure 7C, bottom) . This analysis predicted that FOXO1 preferentially bound to gene loci that are transcriptionally active in MP cells and repressed in TE cells. Pathway analysis of the FOXO1-bound sites within 2 kb of consensus peaks in CD8 + T cells showed that chromatin organization and histone modifications were the most highly enriched biological processes, suggesting a potentially important role for FOXO1 in regulating the chromatin state of CD8 + T cells ( Figure S7 ). Collectively, these results provide a deeper mechanistic understanding of how and when memory cell potential and longevity is gained or lost in effector CD8 + T cells during viral infection-decreased FOXO1 expression and binding to pro-memory genes in TE cells may allow for increased PRC2 activity and stable epigenetic repression, leading to the determination of a TE cell fate. Concurrently, increased FOXO1 expression in developing MP cells may shield pro-memory genes from H3K27me3 deposition, allowing for sustained or even increased expression as memory CD8 
DISCUSSION
The mechanisms underlying differentiation and commitment of effector and memory CD8 + T cells is an active area of investigation. While the asymmetric cell division, signal-strength, and decreasing-potential models seek to explain how the TE and MP cell populations become distinct (Kaech and Cui, 2012) , they do not explain how or when TE cells become committed to their identity and lose memory cell potential and longevity, nor how MP cells remain plastic to form diverse memory cell populations that can regenerate effector cells. Our study illuminated mechanisms for how this occurred by identifying that several pro-memory and pro-survival genes were selectively remodeled in developing KLRG1 hi IL-7R lo TE cells to contain greater H3K27me3 and lesser H3K27ac deposition, which more stably restricted transcription and consequently memory cell potential and lifespan. KLRG1 lo IL-7R hi MP cells, on the other hand, maintained pro-memory, pro-survival, and TE-signature gene loci in active or permissive epigenetic states, allowing for the present expression of ''memory'' genes and the future expression of ''effector'' genes. Further, we showed that PRC2 complex members EZH2 and EED were required for effector cell expansion and the differentiation of KLRG1 hi IL-7R lo TE cells and that PRC2 activity may be restrained at MP-signature genes by FOXO1. These data provided mechanistic insight for how developmental plasticity was epigenetically wired in subsets of effector CD8 + T cells or lost in others as they terminally differentiated. In many respects, the epigenetic changes in TE cells resembled those in stem cells differentiating into specialized cell types-that is, the cells turned on lineage-determining genes (i.e., TE-signature genes) and silenced stemness genes (i.e., MPsignature genes). However, an important distinction in MP cells compared to embryonic stem cells is that EZH2 helps to preserve embryonic stem cell identity by depositing H3K27me3 and repressing lineage-determining genes (Chen and Dent, Figure S6 . 2014); contrastingly, our data showed that MP cells maintained TE-signature genes in a permissive state rather than a repressed state. Our data more clearly delineated a stepwise process from specification to determination of TE fates during viral infection. While transcriptional repression of pro-memory genes occurs rapidly after CD8 + T cell activation (Best et al., 2013) , our results showed that this early transcriptional repression occurred independent of EZH2. Moreover, the pro-memory loci Tcf7 and Bach2 were not as heavily H3K27me3 methylated in KLRG1 hi cells at day 4.5 p.i. as compared to day 10 p.i. Thus, despite being committed to a TE cell fate at day 4.5, evidence of more stable epigenetic repression of pro-memory genes in TE cells did not occur until several days later; this suggested that determination of TE cell fates occurred at later stages of effector cell differentiation and H3K27me3 stabilized already repressed gene loci, similar to what has been observed in thymocyte lineage commitment (Zhang et al., 2012) . Epigenetic silencing by DNA methylation also regulates CD8 + T cell effector formation (Scharer et al., 2013; Ladle et al., 2016) and therefore it will be important to study the temporal and spatial relationship between H3K27me3 and DNA methylation in effector CD8 + T cells.
Prior work mapping genome-wide changes in histone acetylation and methylation in virus-specific effector and memory cells after murine influenza infection (Russ et al., 2014) demonstrated that many genes were epigenetically remodeled during the effector to memory transition. Although epigenetic differences between effector T cell subsets were not compared, as done here, it is possible that such changes occurred over time because of selective maintenance of IL-7R hi MP cells. It is also possible that these changes occurred due to active removal of H3K27me3 in the memory cells and their progenitors by the H3K27me3-specific demethylases UTX and JMJD3 (Manna et al., 2015) . Of interest, the mRNA expression of Utx and Jmjd3 is increased between the effector to memory cell transition (Kaech et al., 2002) . What drives this pro-memory gene-specific, late deposition of H3K27me3 in TE cells? Given that sustained mTOR activity was found to drive TE cell differentiation and impair memory cell development (Kaech and Cui, 2012; Pollizzi et al., 2015) , in part due to impaired FOXO1 activity (Kim et al., 2013) , we reasoned that FOXO1 may be an interesting candidate to consider in regulating PRC2 activity. Moreover, FOXP3, another fork-head box TF family member, was found to bind to EZH2 and regulate PRC2 activity in Treg cells (DuPage et al., 2015; Arvey et al., 2014) . Indeed, our data suggested that FOXO1 prevented deposition of H3K27me3 on certain pro-memory genes in CD8 + T cells. Although we were not able to demonstrate biochemical interaction between FOXO1 and PRC2 subunits in co-immunoprecipitation experiments in effector CD8 + T cells (data not shown), we found that Foxo1 deficiency, but not T-bet OE or Stat4 deficiency, led to increased H3K27me3 levels at certain pro-memory genes in KLRG1
hi IL-7R lo LCMV-specific effector hi , IRF4 hi cells may lead to nuclear exclusion followed by ubiquitination, acetylation, and proteosomal degradation of FOXO1, which commits the effector cells to terminal differentiation (Chang et al., 2011; Staron et al., 2014; Lin et al., 2015) . Altogether, our data suggested that FOXO1 may regulate PRC2-mediated deposition of H3K27me3 in CD8 + T cells as they terminally differentiated; however, future studies are required to clarify the precise mechanism of FOXO1 regulation.
Our data also highlighted the role of epigenetic bivalency, where a locus contains both active-and repressive-associated histone modifications, in cellular differentiation. Similar to previous studies in CD8 + T cells (Russ et al., 2014; Araki et al., 2009), we found that many genes were bivalently modified during CD8 + T cell differentiation. Further, we found that the relative ratio of H3K27ac/H3K27me3 differed between MP and TE cells at numerous differentially expressed genes. TE cells had a lower relative ratio of H3K27ac/H3K27me3 than MP cells at many pro-memory and pro-survival genes, suggesting that the relative level, not simple presence or absence, of repressive to activating epigenetic modifications determined whether repressed promemory genes became stably epigenetically silenced. An alternative explanation of the observed bivalency is undistinguished heterogeneity in the TE and MP populations, wherein cells may differ epigenetically despite sharing the same population identifying surface markers. While 90% of TE cells appear stably terminally differentiated, we have previously shown that $10% of these cells transform into IL-7R hi cells (Joshi et al., 2007) .
Thus, there may be some convertibility within this subset and it could involve epigenetic remodeling and erasing of H3K27me3 from the pro-memory gene loci in response to different stresses or tissue environments. In summary, this work identified a model for how memory cell potential was lost as effector CD8 + T cells terminally differentiated through epigenetic silencing of genes controlling T cell survival and memory cell fates and adds to our growing understanding of the profound importance of epigenetic regulation in T cell plasticity and developmental potential (Vahedi et al., 2012) .
EXPERIMENTAL PROCEDURES
Mice, Infections, and Treatments C57BL/6 (B6) mice were purchased from Charles River Laboratories. P14 (LCMV H-2D b GP 33-41 specific) T cell receptor (TCR) transgenic mice were obtained from R. Ahmed (Pircher et al., 1989) . Ezh2 flox/flox (Shen et al., 2008) , Eed flox/flox (Xie et al., 2014) , and CD4Cre (Lee et al., 2001 ) mice were purchased from Jackson Laboratories. GranzymeB-Cre (GzmBCre) mice (Jacob and Baltimore, 1999) were provided by J. Jacob (Emory University, Atlanta, GA (Shen et al., 2008) . All animal experiments were completed according to approved Institutional Animal Care and Use Committee protocols. Details of infections and treatments are found in the Supplemental Experimental Procedures.
Gene Expression by qRT-PCR and Immunoblotting
Immunoblotting was performed as previously described using rabbit monoclonal antibodies from Cell Signaling: EZH2 (D2C9), b-Actin (13E5), H3K27me3 (C62B11), and H3 (D1H2) (Hand et al., 2007 
Mixed Bone Marrow Chimeras and Retroviral Everexpression
MSCV-empty-vector-GFP and MSCV-T-bet-GFP (Tbet-overexpression) (Szabo et al., 2000) were obtained from L. Glimcher (Dana Farber, Boston, MA). Details of these procedures are found in the Supplemental Experimental Procedures.
Statistical Analysis
Results from flow cytometry and qPCR data were presented as mean ± standard deviation. Statistical significance was computed with Prism 7 (GraphPad Software) by paired or unpaired Student's t test with a p value of < 0.05 considered as significant. Details of statistical analysis for ChIP-seq data are found in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
Data are available online at the Gene Expression Omnibus (GEO: GSE72408) and the Sequence Read Archive (SRA: SRA273724 and SRP101899). 
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